Is there a generic for pradaxa?

Yes—Pradaxa (the brand name for the anticoagulant dabigatran etexilate) does have a generic form. The generic is simply dabigatran etexilate (often sold as “dabigatran” in the package). The generic is bioequivalent to Pradaxa, meaning it has the same active ingredient, strength, dosage form, and therapeutic effect.

Key points about the generic:

| Feature | Pradaxa (brand) | Generic dabigatran etexilate |
|---------|------------------|------------------------------|
| Active ingredient | Dabigatran etexilate | Dabigatran etexilate |
| Dosage strength | 110 mg, 150 mg, 220 mg capsules | Same strengths (often 110 mg or 150 mg capsules) |
| Indications | Prevention of stroke in non‑valvular atrial fibrillation; treatment/secondary prevention of deep vein thrombosis (DVT) or pulmonary embolism (PE) | Same indications |
| Approval | FDA‑approved 2010 | FDA‑approved generic 2023 (varies by country) |
| Cost | Typically higher due to brand premium | Usually lower, especially with insurance coverage or pharmacy discounts |

Availability

• United States: Generic dabigatran was approved by the FDA in 2023, so many pharmacies now carry it.
  
• Other countries: Availability varies by national regulatory approval and market. Check local drug databases or speak to a pharmacist.
  
  

When considering switching

• Consult your clinician: They can confirm that a switch is appropriate for your specific clinical scenario.
  
• Insurance coverage: Many plans cover the generic at a lower copay. Ask your insurer about formulary status.
  
• Monitoring: The generic has the same monitoring requirements (e.g., renal function checks, bleeding risk assessment).
  
  ---
  
  If you’re thinking about switching or just want to confirm that the generic is available in your area, a quick call to your pharmacy or a visit to their website can give you the most up‑to‑date information. And of course, keep your healthcare provider in the loop whenever you make changes to your medication regimen.